Puma Biotechnology reported $3.45M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Alnylam Pharmaceuticals ALNY:US $ 32.52M 4M
Amgen AMGN:US $ 285M 33M
Arena Pharmaceuticals ARNA:US $ 1.07M 0.02M
Array Technologies Inc ARRY:US 9.01M 2.19M
Biogen BIIB:US $ 56.4M 8.3M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Esperion Therapeutics ESPR:US $ 8.12M 806K
Gilead Sciences GILD:US $ 256M 1M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
Moderna Inc MRNA:US 3M 506K
Novartis NOVN:VX 202M 1000K
Pfizer PFE:US $ 316M 20M
Ptc Therapeutics PTCT:US $ 22.56M 2.7M
Puma Biotechnology PBYI:US $ 3.45M 0.12M
Regeneron Pharmaceuticals REGN:US $ 14.6M 0.2M
Sarepta Therapeutics SRPT:US $ 15.65M 3.08M
Tg Therapeutics TGTX:US $ 1.9M 0.61M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
YTE INCY:US $ 0.36M 0.07M